Neurotech Appoints Beth Marsh as Chief Commercial Officer
April 21, 2025
Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced the appointment of Beth Marsh as Chief Commercial